Join now to get access to this content and more.
Become a SOAP member and have access to our benefits.
- Sample Centers of Excellence Applications
- ACOG Documents
- SOAP Policy and Procedure Manual (P&P Manual)
- SOAP Neuraxial Morphine Consensus Statement for Membership Review
- SOAP's Learning Modules
- ASA Corner
- 2019 Annual Meeting Lecture Videos
- December 2018 - SOAP Unofficial Guide to ASA Committees Webinar
- Submit a Position
- View Job Postings
- Search our Patient Safety Archive
- Ask SOAP a Question
- Our Bylaws
- Previous Meeting Archives
- Newsletter Archives
- Newsletter Clinical Articles
- Annual Meeting Publications
- CMS Guidelines
- Clinician Education
- And more…
Use of Thromboelastogram in Case of Placenta Previa with DIC
Abstract Number: 122
Abstract Type: Case Report/Case Series
With a greater number of cesarean sections (CS) being performed today, the incidence of placental disorders is rapidly escalating. Morbidly adherent placentation leading to uncontrollable hemorrhage is now the primary indication for peripartum hysterectomy . In the face of massive hemorrhage, coagulopathy may be inevitable. Routine laboratory tests may not adequately reflect the dynamic status of hemostasis and are argued to be poor predictors of bleeding risk . Several experts have advocated the use of thromboelastography in managing intraoperative bleeding and guiding the use of transfusion products.
We report a case in which the latter was used to guide management for a patient with placenta percreta who developed severe intraoperative coagulopathy. A 38 yr old G8P5024, with a history of 3 previous CS, presented at 32 wks gestation with a diagnosis of placenta previa and suspected invasion of the urinary bladder, based on ultrasound and MRI. She was scheduled for cystoscopy and bilateral ureteral stent placement, followed by cesarean hysterectomy under general anesthesia. The uterus was found to be distinctly adherent to the posterior wall of the bladder, and intentional cystotomy was performed revealing posterior bladder invasion. Massive hemorrhage and coagulopathy ensued. Serial thromboelastograms, which at first revealed no sign of clot formation, were used to guide our transfusion decisions. EBL was 9L, and she ultimately received 17 units of PRBC’s, 16 units of FFP, 15 units of platelets, 10 units of cryoprecipitate and 6L of crystalloid.
Antepartum diagnosis and careful planning in cases of placenta percreta is imperative and should involve a multidisciplinary team approach. By providing the ability to comprehensively evaluate the hemodynamic picture (coagulation factors, platelet function and fibrinolysis), use of thomboelastography should be considered when massive hemorrhage is anticipated.
1. Flood KM, Said SF, Geary MF, et al. Changing trends in peripartum hysterectomy
over the last 4 decades. AM J Obstet Gynecol 2009; 200:632.e1-632.e6.
2. Levy JH, Dutton, RP, Hemphill JC, et al. Multidisciplinary approach to the challenge
of hemostasis. Anesth Anal 2010; 110:354-64.
3. Steer PL, Finley BE, Blumenthal LA. Abruptio placentae and disseminated
intravascular coagulation: use of thrombelastography and sonoclot analysis.
International Journal of Obstetric Anesthesia 1994; 3: 229-233.